Alex assists clients with the full range of patent activities, including drafting and prosecuting domestic and international patent applications, managing global patent portfolios, conducting freedom-to-operate and patentability analyses, and supporting due diligence in connection with venture capital investment and M&A transactions.
She has extensive experience with next-generation cell therapies, including CAR-T and CAR-B cell technologies, as well as RNA-based therapeutics such as mRNA vaccines and lipid nanoparticle delivery systems. Alex is well-versed in CRISPR-Cas genome editing, bispecific and anti-CD20 antibodies, gene therapy vectors, and large molecule biologics.
Alex also has a significant background in patent litigation, including Hatch-Waxman, PTAB and IPR proceedings. Alex’s litigation experience informs her daily patent prosecution strategies, making her a strong client advocate.
University of California, Berkeley
Berkeley, CA
Ph.D. in Molecular and Cell Biology
San Francisco State University
San Francisco, CA
B.S. in Cell and Molecular Biology
Minority Access to Research Careers Scholar
UCLA School of Law
Los Angeles, CA
J.D.
Public Interest Law Foundation Grant Recipient;
Joseph Drown Foundation Scholar;
Associate Editor, Chicano-Latino Law Review
Harvard University
Cambridge, MA
B.A. in Fine Arts
John Harvard Academic Scholarship
Elizabeth Cary Agassiz Certificate of Merit
Dean’s List
California
U.S. Patent and Trademark Office
ACLU Community Service Award – 2021